First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published: April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Smoothies vs juice: study reveals which fruit form is healthiest April 17, 2026 Pre-pregnancy weight loss surgery type may affect child’s early weight gain June 3, 2024 Targeting Individual Frailty Traits May Prevent Falls Among the Elderly May 23, 2025